This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Radu, A.
Right arrow Articles by Georgescu, M.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Radu, A.
Right arrow Articles by Georgescu, M.-M.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, September 2003, p. 6139-6149, Vol. 23, No. 17
0270-7306/03/$08.00+0     DOI: 10.1128/MCB.23.17.6139-6149.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

PTEN Induces Cell Cycle Arrest by Decreasing the Level and Nuclear Localization of Cyclin D1

Aurelian Radu,1 Valerie Neubauer,2 Tsuyoshi Akagi,3 Hidesaburo Hanafusa,3 and Maria-Magdalena Georgescu2,4*

Carl C. Icahn Institute for Gene Therapy and Molecular Medicine, Mount Sinai School of Medicine, New York, New York,1 Department of Neuro-Oncology,2 Department of Molecular Genetics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas,4 Osaka Bioscience Institute, Suita, Osaka 565-0874, Japan3

Received 12 November 2002/ Returned for modification 19 December 2002/ Accepted 2 June 2003

PTEN is a tumor suppressor frequently inactivated in brain, prostate, and uterine cancers that acts as a phosphatase on phosphatidylinositol-3,4,5-trisphosphate, antagonizing the activity of the phosphatidylinositol 3'-OH kinase. PTEN manifests its tumor suppressor function in most tumor cells by inducing G1-phase cell cycle arrest. To study the mechanism of cell cycle arrest, we established a tetracycline-inducible expression system for PTEN in cell lines lacking this gene. Expression of wild-type PTEN but not of mutant forms unable to dephosphorylate phosphoinositides reduced the expression of cyclin D1. Cyclin D1 reduction was accompanied by a marked decrease in endogenous retinoblastoma (Rb) protein phosphorylation on cyclin D/CDK4-specific sites, showing an early negative effect of PTEN on Rb inactivation. PTEN expression also prevented cyclin D1 from localizing to the nucleus during the G1- to S-phase cell cycle transition. The PTEN-induced localization defect and the cell growth arrest could be rescued by the expression of a nucleus-persistent mutant form of cyclin D1, indicating that an important effect of PTEN is at the level of nuclear availability of cyclin D1. Constitutively active Akt/PKB kinase counteracted the effect of PTEN on cyclin D1 translocation. The data are consistent with an oncogenesis model in which a lack of PTEN fuels the cell cycle by increasing the nuclear availability of cyclin D1 through the Akt/PKB pathway.


* Corresponding author. Mailing address: The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Box 316, Houston, TX 77030-4095. Phone: (713) 792-4150. Fax: (713) 745-1183. E-mail: mgeorges{at}mdanderson.org.


Molecular and Cellular Biology, September 2003, p. 6139-6149, Vol. 23, No. 17
0022-538X/03/$08.00+0     DOI: 10.1128/MCB.23.17.6139-6149.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Mosessian, S., Avliyakulov, N. K., Mulholland, D. J., Boontheung, P., Loo, J. A., Wu, H. (2009). Analysis of PTEN Complex Assembly and Identification of Heterogeneous Nuclear Ribonucleoprotein C as a Component of the PTEN-associated Complex. J. Biol. Chem. 284: 30159-30166 [Abstract] [Full Text]  
  • Fournier, M. V., Fata, J. E., Martin, K. J., Yaswen, P., Bissell, M. J. (2009). Interaction of E-cadherin and PTEN Regulates Morphogenesis and Growth Arrest in Human Mammary Epithelial Cells. Cancer Res. 69: 4545-4552 [Abstract] [Full Text]  
  • Chung, J.-Y., Hong, S.-M., Choi, B. Y., Cho, H., Yu, E., Hewitt, S. M. (2009). The Expression of Phospho-AKT, Phospho-mTOR, and PTEN in Extrahepatic Cholangiocarcinoma. Clin. Cancer Res. 15: 660-667 [Abstract] [Full Text]  
  • Ristorcelli, E., Beraud, E., Verrando, P., Villard, C., Lafitte, D., Sbarra, V., Lombardo, D., Verine, A. (2008). Human tumor nanoparticles induce apoptosis of pancreatic cancer cells. FASEB J. 22: 3358-3369 [Abstract] [Full Text]  
  • Woiwode, A., Johnson, S. A. S., Zhong, S., Zhang, C., Roeder, R. G., Teichmann, M., Johnson, D. L. (2008). PTEN Represses RNA Polymerase III-Dependent Transcription by Targeting the TFIIIB Complex. Mol. Cell. Biol. 28: 4204-4214 [Abstract] [Full Text]  
  • Raven, J. F., Baltzis, D., Wang, S., Mounir, Z., Papadakis, A. I., Gao, H. Q., Koromilas, A. E. (2008). PKR and PKR-like Endoplasmic Reticulum Kinase Induce the Proteasome-dependent Degradation of Cyclin D1 via a Mechanism Requiring Eukaryotic Initiation Factor 2{alpha} Phosphorylation. J. Biol. Chem. 283: 3097-3108 [Abstract] [Full Text]  
  • Koslowski, M., Sahin, U., Mitnacht-Kraus, R., Seitz, G., Huber, C., Tureci, O. (2007). A Placenta-Specific Gene Ectopically Activated in Many Human Cancers Is Essentially Involved in Malignant Cell Processes. Cancer Res. 67: 9528-9534 [Abstract] [Full Text]  
  • Kao, G. D., Jiang, Z., Fernandes, A. M., Gupta, A. K., Maity, A. (2007). Inhibition of Phosphatidylinositol-3-OH Kinase/Akt Signaling Impairs DNA Repair in Glioblastoma Cells following Ionizing Radiation. J. Biol. Chem. 282: 21206-21212 [Abstract] [Full Text]  
  • Blanco-Aparicio, C., Renner, O., Leal, J. F.M., Carnero, A. (2007). PTEN, more than the AKT pathway. Carcinogenesis 28: 1379-1386 [Abstract] [Full Text]  
  • Jiang, Z., Pore, N., Cerniglia, G. J., Mick, R., Georgescu, M.-M., Bernhard, E. J., Hahn, S. M., Gupta, A. K., Maity, A. (2007). Phosphatase and Tensin Homologue Deficiency in Glioblastoma Confers Resistance to Radiation and Temozolomide that Is Reversed by the Protease Inhibitor Nelfinavir. Cancer Res. 67: 4467-4473 [Abstract] [Full Text]  
  • Ward, W. O., Delker, D. A., Hester, S. D., Thai, S.-F., Wolf, D. C., Allen, J. W., Nesnow, S. (2006). Transcriptional Profiles in Liver from Mice Treated with Hepatotumorigenic and Nonhepatotumorigenic Triazole Conazole Fungicides: Propiconazole, Triadimefon, and Myclobutanil. Toxicol Pathol 34: 863-878 [Abstract] [Full Text]  
  • Chung, J.-H., Ostrowski, M. C., Romigh, T., Minaguchi, T., Waite, K. A., Eng, C. (2006). The ERK1/2 pathway modulates nuclear PTEN-mediated cell cycle arrest by cyclin D1 transcriptional regulation. Hum Mol Genet 15: 2553-2559 [Abstract] [Full Text]  
  • Packer, L., Pavey, S., Parker, A., Stark, M., Johansson, P., Clarke, B., Pollock, P., Ringner, M., Hayward, N. (2006). Osteopontin is a downstream effector of the PI3-kinase pathway in melanomas that is inversely correlated with functional PTEN. Carcinogenesis 27: 1778-1786 [Abstract] [Full Text]  
  • Gil, A., Andres-Pons, A., Fernandez, E., Valiente, M., Torres, J., Cervera, J., Pulido, R. (2006). Nuclear Localization of PTEN by a Ran-dependent Mechanism Enhances Apoptosis: Involvement of an N-Terminal Nuclear Localization Domain and Multiple Nuclear Exclusion Motifs. Mol. Biol. Cell 17: 4002-4013 [Abstract] [Full Text]  
  • Szivak, I., Lamb, N., Heilmeyer, L. M. G. (2006). Subcellular Localization and Structural Function of Endogenous Phosphorylated Phosphatidylinositol 4-Kinase (PI4K92). J. Biol. Chem. 281: 16740-16749 [Abstract] [Full Text]  
  • Zhang, C.-L., Zou, Y., Yu, R. T., Gage, F. H., Evans, R. M. (2006). Nuclear receptor TLX prevents retinal dystrophy and recruits the corepressor atrophin1.. Genes Dev. 20: 1308-1320 [Abstract] [Full Text]  
  • Stiles, B. L., Kuralwalla-Martinez, C., Guo, W., Gregorian, C., Wang, Y., Tian, J., Magnuson, M. A., Wu, H. (2006). Selective Deletion of Pten in Pancreatic {beta} Cells Leads to Increased Islet Mass and Resistance to STZ-Induced Diabetes.. Mol. Cell. Biol. 26: 2772-2781 [Abstract] [Full Text]  
  • Kaper, F., Dornhoefer, N., Giaccia, A. J. (2006). Mutations in the PI3K/PTEN/TSC2 Pathway Contribute to Mammalian Target of Rapamycin Activity and Increased Translation under Hypoxic Conditions. Cancer Res. 66: 1561-1569 [Abstract] [Full Text]  
  • Hill, R., Song, Y., Cardiff, R. D., Van Dyke, T. (2005). Heterogeneous Tumor Evolution Initiated by Loss of pRb Function in a Preclinical Prostate Cancer Model. Cancer Res. 65: 10243-10254 [Abstract] [Full Text]  
  • Nadella, K. S., Kirschner, L. S. (2005). Disruption of Protein Kinase A Regulation Causes Immortalization and Dysregulation of D-Type Cyclins. Cancer Res. 65: 10307-10315 [Abstract] [Full Text]  
  • Rampalli, S., Pavithra, L., Bhatt, A., Kundu, T. K., Chattopadhyay, S. (2005). Tumor Suppressor SMAR1 Mediates Cyclin D1 Repression by Recruitment of the SIN3/Histone Deacetylase 1 Complex. Mol. Cell. Biol. 25: 8415-8429 [Abstract] [Full Text]  
  • Yang, L., Mao, C., Teng, Y., Li, W., Zhang, J., Cheng, X., Li, X., Han, X., Xia, Z., Deng, H., Yang, X. (2005). Targeted Disruption of Smad4 in Mouse Epidermis Results in Failure of Hair Follicle Cycling and Formation of Skin Tumors. Cancer Res. 65: 8671-8678 [Abstract] [Full Text]  
  • Chung, J.-H., Eng, C. (2005). Nuclear-Cytoplasmic Partitioning of Phosphatase and Tensin Homologue Deleted on Chromosome 10 (PTEN) Differentially Regulates the Cell Cycle and Apoptosis. Cancer Res. 65: 8096-8100 [Abstract] [Full Text]  
  • Zhang, C., Comai, L., Johnson, D. L. (2005). PTEN Represses RNA Polymerase I Transcription by Disrupting the SL1 Complex. Mol. Cell. Biol. 25: 6899-6911 [Abstract] [Full Text]  
  • Chung, J.-H., Ginn-Pease, M. E., Eng, C. (2005). Phosphatase and Tensin Homologue Deleted on Chromosome 10 (PTEN) Has Nuclear Localization Signal-Like Sequences for Nuclear Import Mediated by Major Vault Protein. Cancer Res. 65: 4108-4116 [Abstract] [Full Text]  
  • Subauste, M. C., Nalbant, P., Adamson, E. D., Hahn, K. M. (2005). Vinculin Controls PTEN Protein Level by Maintaining the Interaction of the Adherens Junction Protein {beta}-Catenin with the Scaffolding Protein MAGI-2. J. Biol. Chem. 280: 5676-5681 [Abstract] [Full Text]  
  • Eason, R. R., Velarde, M. C., Chatman, L. Jr, Till, S. R., Geng, Y., Ferguson, M., Badger, T. M., Simmen, R. C. M. (2004). Dietary Exposure to Whey Proteins Alters Rat Mammary Gland Proliferation, Apoptosis, and Gene Expression during Postnatal Development. J. Nutr. 134: 3370-3377 [Abstract] [Full Text]  
  • Lee, C., Kim, J.-S., Waldman, T. (2004). PTEN Gene Targeting Reveals a Radiation-Induced Size Checkpoint in Human Cancer Cells. Cancer Res. 64: 6906-6914 [Abstract] [Full Text]